Zomedica Pharmaceuticals Stock Forecast - Accumulation Distribution

ZOM Stock  USD 0.12  0  2.50%   
Zomedica Stock Forecast is based on your current time horizon. Although Zomedica Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Zomedica Pharmaceuticals' systematic risk associated with finding meaningful patterns of Zomedica Pharmaceuticals fundamentals over time.
  
At this time, Zomedica Pharmaceuticals' Payables Turnover is very stable compared to the past year. As of the 13th of December 2024, Fixed Asset Turnover is likely to grow to 1.73, while Inventory Turnover is likely to drop 1.02. . As of the 13th of December 2024, Common Stock Shares Outstanding is likely to grow to about 1 B, while Net Loss is likely to drop (16.1 M).
Zomedica Pharmaceuticals Corp has current Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which Zomedica Pharmaceuticals is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Zomedica Pharmaceuticals Corp to determine if accumulation or reduction is taking place in the market. This value is adjusted by Zomedica Pharmaceuticals trading volume to give more weight to distributions with higher volume over lower volume.
Check Zomedica Pharmaceuticals VolatilityBacktest Zomedica PharmaceuticalsInformation Ratio  

Zomedica Pharmaceuticals Trading Date Momentum

On December 13 2024 Zomedica Pharmaceuticals Corp was traded for  0.12  at the closing time. Highest Zomedica Pharmaceuticals's price during the trading hours was 0.12  and the lowest price during the day was  0.12 . There was no trading activity during the period 0.0. Lack of trading volume on the 13th of December 2024 had no short-term effect on price fluctuation. The trading date delta to current price is 2.44% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Zomedica Pharmaceuticals to competition

Other Forecasting Options for Zomedica Pharmaceuticals

For every potential investor in Zomedica, whether a beginner or expert, Zomedica Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zomedica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zomedica. Basic forecasting techniques help filter out the noise by identifying Zomedica Pharmaceuticals' price trends.

View Zomedica Pharmaceuticals Related Equities

 Risk & Return  Correlation

Zomedica Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Zomedica Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Zomedica Pharmaceuticals' current price.

Zomedica Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Zomedica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zomedica Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zomedica Pharmaceuticals stock market strength indicators, traders can identify Zomedica Pharmaceuticals Corp entry and exit signals to maximize returns.

Zomedica Pharmaceuticals Risk Indicators

The analysis of Zomedica Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zomedica Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zomedica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Zomedica Pharmaceuticals is a strong investment it is important to analyze Zomedica Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zomedica Pharmaceuticals' future performance. For an informed investment choice regarding Zomedica Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Zomedica Pharmaceuticals to cross-verify your projections.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.06)
Revenue Per Share
0.027
Quarterly Revenue Growth
0.018
Return On Assets
(0.09)
Return On Equity
(0.24)
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.